Systematic review of the relationship between the 3-hydroxycotinine/ cotinine ratio and cigarette dependence

Psychopharmacology

Volumn 218, Issue 2, 2011, Pages 313-322

  West, Oliver ^a   Hajek, Peter ^a   McRobbie, Hayden ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dependence; Metabolism; Nicotine; Smoking

Indexed keywords

3 HYDROXYCOTININE; AMFEBUTAMONE; COTININE; CYTOCHROME P450 2A6; NICOTINE; NICOTINE PATCH; PLACEBO; UNCLASSIFIED DRUG;

CLINICAL ASSESSMENT TOOL; CYP2A6 GENE; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG METABOLISM; GENE; GENOTYPE; HOMOZYGOSITY; HUMAN; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RATE OF NICOTINE METABOLISM; RELIABILITY; REVIEW; SMOKING; SMOKING CESSATION; SMOKING TOPOGRAPHY; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TOPOGRAPHY; TREATMENT RESPONSE; VALIDITY; WITHDRAWAL SYNDROME;

COTININE; HUMANS; NICOTINE; REPRODUCIBILITY OF RESULTS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 82955237432     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2341-1     Document Type: Review

References (41)

1. N Al Koudsi JC Mwenifumbo EM Sellers NL Benowitz GE Swan RF Tyndale 2006 Characterization of the novel CYP2A621 allele using in vivo nicotine kinetics Eur J Clin Pharmacol 62 481 484 16758265 10.1007/s00228-006-0113-3 1:CAS:528:DC%2BD28XltlOjurY%3D (Pubitemid 43873720)
2. TB Baker ME Piper DE McCarthy DM Bolt SS Smith S-Y Kim S Colby D Conti GA Giovino D Hatsukami A Hyland S Krishnan-Sarin R Niaura KA Perkins BA Toll Transdisciplinary Tobacco Use Research Center 2007 Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence Nicotine Tob Res 9 Suppl 4 S555 S570 18067032
3. Benowitz NL (2001) Compensatory smoking of low yield cigarettes. In: Shopland DR, Burns DM, Benowitz NL, Amacher RH (eds) Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and tobacco control monograph No. 13. US National Institutes of Health, National Cancer Institute, Bethesda
4. NL Benowitz P Jacob 1994 Metabolism of nicotine to cotinine studied by a dual stable-isotope method Clin Pharmacol Ther 56 483 493 7955812 10.1038/clpt.1994.169 1:CAS:528:DyaK2MXis1yjur4%3D (Pubitemid 24370355)
5. NL Benowitz P Jacob RT Jones J Rosenberg 1982 Interindividual variability in the metabolism and cardiovascular effects of nicotine in man J Pharmacol Exp Ther 221 368 372 7077531 1:CAS:528:DyaL38XktFyru7Y%3D (Pubitemid 12122952)
6. NL Benowitz OF Pomerleau CS Pomerleau P Jacob 3rd 2003 Nicotine metabolite ratio as a predictor of cigarette consumption Nicotine Tob Res 5 621 624 14577978 10.1080/1462220031000158717 1:CAS:528:DC%2BD3sXosVGisrk%3D (Pubitemid 37304836)
7. NL Benowitz GE Swan P Jacob CN Lessov-Schlaggar RF Tyndale 2006 CYP2A6 genotype and the metabolism and disposition kinetics of nicotine Clin Pharmacol Ther 80 457 467 17112802 10.1016/j.clpt.2006.08.011 1:CAS:528:DC%2BD28Xht1elsrbI (Pubitemid 44767882)
8. I Berlin MJ Gasior ET Moolchan I Berlin MJ Gasior ET Moolchan 2007 Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers Nicotine Tob Res 9 493 498 17454704 10.1080/14622200701243193 1:CAS:528:DC%2BD2sXlsVCgsbs%3D (Pubitemid 46534461)
9. D Dempsey P Tutka P Jacob F Allen K Schoedel RF Tyndale NL Benowitz 2004 Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity Clin Pharmacol Ther 76 64 72 15229465 10.1016/j.clpt.2004.02.011 1:CAS:528:DC%2BD2cXlsVaqtrY%3D (Pubitemid 38844735)
10. KS Derby K Cuthrell C Caberto SG Carmella AA Franke SS Hecht SE Murphy L le Marchandl 2008 Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer Cancer Epidemiol Biomark Prev 17 3526 3535 10.1158/1055-9965.EPI-08-0424 1:CAS:528:DC%2BD1cXhsVOgtLrK
11. JA Fidler MJ Jarvis J Mindell R West 2008 Nicotine intake in cigarette smokers in England: distribution and demographic correlates Cancer Epidemiol Biomark Prev 17 3331 3336 10.1158/1055-9965.EPI-08-0296 1:CAS:528: DC%2BD1cXhsVOgtLzJ
12. TF Heatherton LT Kozlowski RC Frecker KO Fagerstrom 1991 The Fagerstrom Test for Nicotine Dependence-a revision of the Fagerstrom Tolerance Questionnaire Br J Addict 86 1119 1127 1932883 10.1111/j.1360-0443.1991.tb01879. x 1:STN:280:DyaK38%2Fjtlejtg%3D%3D
13. MK Ho JC Mwenifumbo B Zhao EMJ Gillam RF Tyndale 2008 A novel CYP2A6 allele, CYP2A623, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent Pharmacogenet Genomics 18 67 75 18216723 10.1097/FPC.0b013e3282f3606e 1:CAS:528:DC%2BD1cXmt1aqtA%3D%3D (Pubitemid 351161649)
14. MK Ho JC Mwenifumbo N Al Koudsi KS Okuyemi JS Ahluwalia NL Benowitz RF Tyndale 2009 Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers Clin Pharmacol Ther 85 635 643 19279561 10.1038/clpt.2009.19 1:CAS:528:DC%2BD1MXmtVOgur4%3D
15. J Hukkanen P Jacob NL Benowitz 2005 Metabolism and disposition kinetics of nicotine Pharmacol Rev 57 79 115 15734728 10.1124/pr.57.1.3 1:CAS:528:DC%2BD2MXis1Gmtro%3D (Pubitemid 40283970)
16. E Johnstone N Benowitz A Cargill R Jacob L Hinks I Day M Murphy R Walton 2006 Determinants of the rate of nicotine metabolism and effects on smoking behavior Clin Pharmacol Ther 80 319 330 17015050 10.1016/j.clpt.2006.06.011 1:CAS:528:DC%2BD28XhtVWqurvE (Pubitemid 44479751)
17. DB Kandel MC Hu C Schaffran JR Udry NL Benowitz DB Kandel M-C Hu C Schaffran JR Udry NL Benowitz 2007 Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults Am J Epidemiol 165 901 910 17322544 10.1093/aje/kwm010 (Pubitemid 46536667)
18. I Kim A Wtsadik RE Choo HE Jones MA Huestis 2005 Usefulness of salivary trans-3 ′-hydroxycotinine concentration and trans-3 ′- hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women J Anal Toxicol 29 689 695 16419402 1:CAS:528:DC%2BD2MXhtFChsL%2FI (Pubitemid 41803359)
19. Kozlowski LT, O'connor RJ, Sweeney CT (2001) Cigarette design. In: Shopland DR, Burns DM, Benowitz NL, Amacher RH (eds) Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and tobacco control monograph No. 13. US National Institutes of Health, National Cancer Institute, Bethesda
20. RA Lea S Dickson NL Benowitz RA Lea S Dickson NL Benowitz 2006 Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate J Anal Toxicol 30 386 389 16872570 1:CAS:528: DC%2BD28Xnt1aitbs%3D (Pubitemid 44274073)
21. Lerman C (2010) Nicotine dependence treatment: a translational approach. 12th Annual Conference Society for Resesrch on Nicotine and Tobacco Europe. Bath, UK
22. C Lerman R Tyndale F Patterson EP Wileyto PG Shields A Pinto N Benowitz C Lerman R Tyndale F Patterson EP Wileyto PG Shields A Pinto N Benowitz 2006 Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation Clin Pharmacol Ther 79 600 608 16765148 10.1016/j.clpt.2006.02.006 1:CAS:528:DC%2BD28Xltl2ms70%3D (Pubitemid 43817942)
23. C Lerman C Jepson EP Wileyto F Patterson R Schnoll M Mroziewicz N Benowitz RF Tyndale 2010 Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy Clin Pharmacol Ther 87 553 557 20336063 10.1038/clpt.2010.3 1:CAS:528:DC%2BC3cXkvFCntLg%3D
24. V Malaiyandi SD Goodz EM Sellers RF Tyndale 2006 CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking Cancer Epidemiol Biomark Prev 15 1812 1819 10.1158/1055-9965.EPI-05-0723 1:CAS:528:DC%2BD28XhtVGktbjP (Pubitemid 44664253)
25. ES Messina RF Tyndale EM Sellers 1997 A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes J Pharmacol Exp Ther 282 1608 1614 9316878 1:CAS:528:DyaK2sXmsVGlu7s%3D (Pubitemid 27408347)
26. ET Moolchan CS Parzynski M Jaszyna-Gasior CC Collins MK Leff DL Zimmerman 2009 A link between adolescent nicotine metabolism and smoking topography Cancer Epidemiol Biomark Prev 18 1578 1583 10.1158/1055-9965.EPI-08-0592 1:CAS:528:DC%2BD1MXlsFCltLs%3D
27. ME Mooney ZZ Li SE Murphy PR Pentel C Le DK Hatsukami 2008 Stability of the nicotine metabolite ratio in ad libitum and reducing smokers Cancer Epidemiol Biomark Prev 17 1396 1400 10.1158/1055-9965.EPI-08-0242 1:CAS:528:DC%2BD1cXnsVKgt7Y%3D
28. MR Munafo EC Johnstone 2008 Genes and cigarette smoking Addiction 103 893 904 18190672 10.1111/j.1360-0443.2007.02071.x (Pubitemid 351715215)
29. JC Mwenifumbo EM Sellers RF Tyndale 2007 Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking Drug Alcohol Depend 89 24 33 17161559 10.1016/j.drugalcdep.2006.11.012 1:CAS:528:DC%2BD2sXkslCgsbs%3D (Pubitemid 46602868)
30. JC Mwenifumbo N Al Koudsi MK Ho Q Zhou EB Hoffmann EM Sellers RF Tyndale 2008 Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent Hum Mutat 29 679 688 18360915 10.1002/humu.20698 1:CAS:528:DC%2BD1cXmsVOns7Y%3D (Pubitemid 351614592)
31. JC Mwenifumbo CN Lessov-Schlaggar Q Zhou RE Krasnow GE Swan NL Benowitz RF Tyndale 2008 Identification of novel CYP2A61B variants: the CYP2A61B allele is associated with faster in vivo nicotine metabolism Clin Pharmacol Ther 83 115 121 17522595 10.1038/sj.clpt.6100246 1:CAS:528:DC%2BD2sXhsVylt7bE
32. F Patterson RA Schnoll EP Wileyto A Pinto LH Epstein PG Shields LW Hawk RF Tyndale N Benowitz C Lerman 2008 Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion Clin Pharmacol Ther 84 320 325 18388868 10.1038/clpt.2008.57 1:CAS:528:DC%2BD1cXhtVShtr7L
33. ME Piper DE McCarthy DM Bolt SS Smith C Lerman N Benowitz MC Fiore TB Baker 2008 Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM) Nicotine Tob Res 10 1009 1020 18584464 10.1080/14622200802097563 1:CAS:528:DC%2BD1cXnvVSjtrk%3D (Pubitemid 351998437)
34. R Ray RF Tyndale C Lerman 2009 Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes J Neurogenet 23 252 261 19169923 10.1080/01677060802572887 1:CAS:528:DC%2BD1MXps1Kmtrg%3D
35. ML Rubinstein NL Benowitz GM Auerback AB Moscicki 2008 Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers Pediatrics 122 E643 E647 18762498 10.1542/peds.2007-3679
36. MAH Russell JA Stapleton C Feyerabend SM Wiseman G Gustavsson U Sawe P Connor 1993 Targeting heavy smokers in general practice-randomized controlled trial of transdermal nicotine patches Br Med J 306 1308 1312 10.1136/bmj.306.6888.1308 1:STN:280:DyaK3s3pvFWntQ%3D%3D (Pubitemid 23136742)
37. RA Schnoll F Patterson EP Wileyto RF Tyndale N Benowitz C Lerman 2009 Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study Pharmacol Biochem Behav 92 6 11 19000709 10.1016/j.pbb.2008.10.016 1:CAS:528:DC%2BD1MXhtlOmtLc%3D
38. AA Strasser NL Benowitz AG Pinto KZ Tang SS Hecht SG Carmella RF Tyndale CE Lerman 2011 Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level Cancer Epidemiol Biomark Prev 20 234 238 10.1158/1055-9965.EPI-10-0674 1:CAS:528:DC%2BC3MXhsFGntro%3D
39. GE Swan NL Benowitz CN Lessov P Jacob RF Tyndale K Wilhelmsen 2005 Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence Pharmacogenet Genomics 15 115 125 15861035 10.1097/01213011-200502000- 00007 1:CAS:528:DC%2BD2MXivFGjtLo%3D (Pubitemid 40562988)
40. GE Swan CN Lessov-Schlaggar AW Bergen YG He RF Tyndale NL Benowitz 2009 Genetic and environmental influences on the ratio of 3 ′ hydroxycotinine to cotinine in plasma and urine Pharmacogenet Genomics 19 388 398 19300303 10.1097/FPC.0b013e32832a404f 1:CAS:528:DC%2BD1MXksVCls7c%3D
41. West R (2005) Defining and assessing nicotine dependence in humans. In: Corrigall WA (ed) Understanding nicotine and tobacco addiction. Wiley, Chichester